Track topics on Twitter Track topics that are important to you
A nanocomposite consisting of electrochemically reduced graphene oxide, poly(Eriochrome black T) and gold nanoparticles (ERGO-pEBT/AuNPs) was prepared for the simultaneous detection of resorcinol (RC), catechol (CC), and hydroquinone (HQ). The electrochemical oxidation of HQ, CC, and RC was analysed by using cyclic voltammetry and differential pulse voltammetry. Three well-separated potentials were found at 166, 277, and 660 mV (vs. Ag/AgCl) for HQ, CC, and RC, respectively The linear ranges were 0.52-31.4, 1.44-31.2, and 3.8-72.2 μM for HQ, CC, and RC, respectively. The limits of detections (LODs) for both individual and simultaneous detections are negligibly different are (15, 8, and 39 nM, respectively). Graphical abstract Voltammetric determination of hydroquinone, catechol, and resorcinol at ERGO-pEBT/AuNPs resulted in high peak currents and outstanding oxidation potential separation of the analytes.
This article was published in the following journal.
Name: Mikrochimica acta
Voltammetric simultaneous determination of catechol and hydroquinone using a glassy carbon electrode modified with a ternary hybrid material composed of reduced graphene oxide, magnetite nanoparticles and gold nanoparticles.
An electrochemical sensor is described for the simultaneous determination of the pollutants catechol (CC) and hydroquinone (HQ). A glassy carbon electrode (GCE) was modified with reduced graphene oxid...
A glassy carbon electrode was modified with carbon black and CdTe quantum dots in a chitosan film to obtained a sensor for norfloxacin (NOR) in the presence of dopamine, caffeine, and uric acid. The m...
A composite was prepared at room temperature from nitrogen-doped reduced graphene oxide (N-rGO) and melamine via π-interaction. An ultra-sensitive electrochemical sensor for the determination of trac...
The authors describe a simplified chemical precipitation method and silver mirror reaction to synthesize a nanocomposite consiting of silver nanoparticles on a thin and porous nickel oxide film. Place...
Enzyme-free electrochemical detection of nanomolar levels of the organophosphorus pesticide paraoxon-ethyl by using a poly(N-isopropyl acrylamide)-chitosan microgel decorated with palladium nanoparticles.
A rapid voltammetric method is described for the determination of the organophosphorus pesticide paraoxon-ethyl (PEL). A glassy carbon electrode (GCE) was modified with a composite consisting of a pol...
To assess the ability of a new 4% Hydroquinone formulation (Melanoderm 4% Crema) to reduce melasma on the face, using a split-face randomization design, evaluating the MASI Score from base...
This study will enroll 20 adult Hispanic women. Participants will apply 4% hydroquinone cream twice daily to affected areas on the face for 14 weeks and half the face will be peeled with ...
This study assess the effectiveness of oral tranexamic acid in combination with hydroquinone cream in the treatment of melasma.
The objective of this study is to evaluate the efficacy and tolerability of Lytera 2.0 versus 4% hydroquinone in the improvement of the appearance of moderate facial melasma.
A Comparative study for Efficacy and Safety Between 4% hydroquinone cream with or without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma
Enzyme that catalyzes the movement of a methyl group from S-adenosylmethionone to a catechol or a catecholamine. EC 220.127.116.11.
An enzyme that catalyzes the oxidation of catechol to muconic acid with the use of Fe3+ as a cofactor. This enzyme was formerly characterized as EC 18.104.22.168 and EC 22.214.171.124.
An enzyme of the oxidoreductase class that catalyzes the reaction between catechol and oxygen to yield benzoquinone and water. It is a complex of copper-containing proteins that acts also on a variety of substituted catechols. EC 126.96.36.199.
Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE.
Catalyzes the oxidation of catechol to 2-hydroxymuconate semialdehyde in the carbazole and BENZOATE degradation via HYDROXYLATION pathways. It also catalyzes the conversion of 3-methylcatechol to cis, cis-2-hydroxy-6-oxohept-2,4-dienoate in the TOLUENE and XYLENE degradation pathway. This enzyme was formerly characterized as EC 188.8.131.52.